1. Home
  2. COHN vs PSTV Comparison

COHN vs PSTV Comparison

Compare COHN & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Company Inc.

COHN

Cohen & Company Inc.

HOLD

Current Price

$18.24

Market Cap

40.3M

Sector

Finance

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$0.26

Market Cap

46.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHN
PSTV
Founded
1999
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.3M
46.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
COHN
PSTV
Price
$18.24
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
32.8K
20.1M
Earning Date
03-09-2026
03-26-2026
Dividend Yield
5.52%
N/A
EPS Growth
6.29
N/A
EPS
2.50
N/A
Revenue
$185,475,000.00
$5,258,000.00
Revenue This Year
N/A
$1.73
Revenue Next Year
N/A
$12.05
P/E Ratio
$7.25
N/A
Revenue Growth
107.11
N/A
52 Week Low
$6.10
$0.16
52 Week High
$32.60
$2.31

Technical Indicators

Market Signals
Indicator
COHN
PSTV
Relative Strength Index (RSI) 47.88 32.55
Support Level $17.34 $0.22
Resistance Level $19.25 $0.26
Average True Range (ATR) 1.35 0.03
MACD -0.19 0.01
Stochastic Oscillator 29.58 44.36

Price Performance

Historical Comparison
COHN
PSTV

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: